Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression

Genes Chromosomes and Cancer

Volumn 49, Issue 3, 2010, Pages 270-281

  Försti, Asta ^a,b   Li, Xuchen ^a   Wagner, Kerstin ^a   Tavelin, Björn ^c   Enquist, Kerstin ^d   Palmqvist, Richard ^d   Altieri, Andrea ^a   Hallmans, Göran ^d   Hemminki, Kari ^a,b   Lenner, Per ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECTAL NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 76649140506     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20738     Document Type: Article

References (37)

1. Akhurst RJ, Derynck R. 2001. TGF-beta signaling in cancer - A double-edged sword. Trends Cell Biol 11:S44-S51.
2. Annes JP, Munger JS, Rifkin DB. 2003. Making sense of latent TGFbeta activation. J Cell Sci 116:217-224.
3. Ayoubi TA, Creemers JW, Roebroek AJ, Van de Ven WJ. 1994. Expression of the dibasic proprotein processing enzyme furin is directed by multiple promoters. J Biol Chem 269:9298-9303.
4. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
5. Berndt SI, Huang WY, Chatterjee N, Yeager M, Welch R, Chanock SJ, Weissfeld JL, Schoen RE, Hayes RB. 2007. Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis 28:1965-1970.
6. Bian Y, Caldes T, Wijnen J, Franken P, Vasen H, Kaklamani V, Nafa K, Peterlongo P, Ellis N, Baron JA, Burn J, Moeslein G, Morrison PJ, Chen Y, Ahsan H, Watson P, Lynch HT, de la Chapelle A, Fodde R, Pasche B. 2005. TGFBR1*6A may contribute to hereditary colorectal cancer. J Clin Oncol 23:3074-3078.
7. Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K, Rowan A, Lubbe S, Spain S, Sullivan K, Fielding S, Jaeger E, Vijayakrishnan J, Kemp Z, Gorman M, Chandler I, Papaemmanuil E, Penegar S, Wood W, Sellick G, Qureshi M, Teixeira A, Domingo E, Barclay E, Martin L, Sieber O, Kerr D, Gray R, Peto J, Cazier JB, Tomlinson I, Houlston RS. 2007. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 39:1315-1317.
8. Castillejo A, Mata-Balaguer T, Montenegro P, Ochoa E, Lazaro R, Martinez-Canto A, Castillejo MI, Guarinos C, Barbera VM, Guillen-Ponce C, Carrato A, Soto JL. 2009. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: A case-control study. BMC Cancer 9:193.
9. Chen JM, Ferec C, Cooper DN. 2006a. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes. I. General principles and overview. Hum Genet 120:1-21.
10. Chen T, Jackson CR, Link A, Markey MP, Colligan BM, Douglass LE, Pemberton JO, Deddens JA, Graff JR, Carter JH. 2006b. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer. Clin Cancer Res 12:392-397.
11. Daley D, Morgan W, Lewis S, Willis J, Elston RC, Markowitz SD, Wiesner GL. 2007. Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia? Cancer Epidemiol Biomark Prev 16:892-894.
12. Densem CG, Mutlak AS, Pravica V, Brooks NH, Yonan N, Hutchinson IV. 2004. A novel polymorphism of the gene encoding furin, a TGF-beta1 activator, and the influence on cardiac allograft vasculopathy formation. Transpl Immunol 13: 185-190.
13. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. 1995. Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270:10618-10624.
14. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC. 2003. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 63:2610-2615.
15. Dupont WD, Plummer WD, Jr. 1998. Power and sample size calculations for studies involving linear regression. Control Clin Trials 19:589-601.
16. Easton DF, Eeles RA. 2008. Genome-wide association studies in cancer. Hum Mol Genet 17:R109-R115.
17. Hannah BL, Misenheimer TM, Pranghofer MM, Mosher DF. 2004. A polymorphism in thrombospondin-1 associated with familial premature coronary artery disease alters Ca2+ binding. J Biol Chem 279:51915-51922.
18. Higashi T, Kyo S, Inoue M, Tanii H, Saijoh K. 2006. Novel functional single nucleotide polymorphisms in the latent transforming growth factor-beta binding protein-1L promoter: Effect on latent transforming growth factor-beta binding protein-1L expression level and possible prognostic significance in ovarian cancer. J Mol Diagn 8:342-350.
19. Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Penegar S, Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL, Walther A, Barclay E, Martin L, Gorman M, Domingo E, Teixeira AS, Kerr D, Cazier JB, Niittymaki I, Tuupanen S, Karhu A, Aaltonen LA, Tomlinson IP, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Cetnarskyj R, Porteous ME, Pharoah PD, Koessler T, Hampe J, Buch S, Schafmayer C, Tepel J, Schreiber S, Volzke H, Chang-Claude J, Hoffmeister M, Brenner H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S, Campbell H, Dunlop MG. 2008. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 40:1426-1435.
20. Kaaks R, Lundin E, Rinaldi S, Manjer J, Biessy C, Soderberg S, Lenner P, Janzon L, Riboli E, Berglund G, Hallmans G. 2002. Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13:307-316.
21. Koski C, Saharinen J, Keski-Oja J. 1999. Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-beta binding protein-1 (LTBP-1) in a cell type-specific manner. J Biol Chem 274: 32619-32630.
22. Massague J, Blain SW, Lo RS. 2000. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
23. Murphy-Ullrich JE, Poczatek M. 2000. Activation of latent TGF-beta by thrombospondin-1: Mechanisms and physiology. Cytokine Growth Factor Rev 11:59-69.
24. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J, Niehrs C. 1999. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401:480-485.
25. Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, Lo RS, Brener D, Yang D, Kirstein L, Oddoux C, Ostrer H, Vineis P, Varesco L, Jhanwar S, Luzzatto L, Massague J, Offit K. 1999. TbetaR-I(6A) is a candidate tumor susceptibility allele. Cancer Res 59:5678-5682.
26. Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyronen PP, Lenner P, Luostarinen T, Love A, Ogmundsdottir H, Stattin P, Tenkanen L, Tryggvadottir L, Virtamo J, Wadell G, Widell A, Lehtinen M, Dillner J. 2007. Nordic biological specimen banks as basis for studies of cancer causes and control - More than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol 46:286-307.
27. Rosman DS, Phukan S, Huang CC, Pasche B. 2008. TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation. Cancer Res 68:1319-1328.
28. Saharinen J, Hyytiainen M, Taipale J, Keski-Oja J. 1999. Latent transforming growth factor-beta binding proteins (LTBPs) - Structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev 10:99-117.
29. Saltzman BS, Yamamoto JF, Decker R, Yokochi L, Theriault AG, Vogt TM, Le Marchand L. 2008. Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia. Cancer Res 68:1236-1244.
30. Sekiya T, Adachi S, Kohu K, Yamada T, Higuchi O, Furukawa Y, Nakamura Y, Nakamura T, Tashiro K, Kuhara S, Ohwada S, Akiyama T. 2004a. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. J Biol Chem 279:6840-6846.
31. Sekiya T, Oda T, Matsuura K, Akiyama T. 2004b. Transcriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signaling. Biochem Biophys Res Commun 320:680-684.
32. Skoglund J, Song B, Dalen J, Dedorson S, Edler D, Hjern F, Holm J, Lenander C, Lindforss U, Lundqvist N, Olivecrona H, Olsson L, Pahlman L, Rutegard J, Smedh K, Tornqvist A, Houlston RS, Lindblom A. 2007. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk. Clin Cancer Res 13:3748-3752.
33. Skoglund Lundin J, Vandrovcova J, Song B, Zhou X, Zelada-Hedman M, Werelius B, Houlston RS, Lindblom A. 2009. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk. Br J Cancer 100:1674-1679.
34. Sparks R, Bigler J, Sibert JG, Potter JD, Yasui Y, Ulrich CM. 2004. TGFbeta1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps. Int J Epidemiol 33:955-961.
35. Sterner-Kock A, Thorey IS, Koli K, Wempe F, Otte J, Bangsow T, Kuhlmeier K, Kirchner T, Jin S, Keski-Oja J, von Melchner H. 2002. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev 16:2264-2273.
36. Xu Y, Pasche B. 2007. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 16 Spec No 1:R14-R20.
37. Zhang HT. 2005. Int7G24A variant of the TGFBR1 gene and cancer risk: A meta-analysis of three case-control studies. Lung Cancer 49:419-420.